125 related articles for article (PubMed ID: 35718555)
1. COVID-19 vaccine effectiveness in adults with developmental disabilities living in group homes.
Hirsch KM; Reidenberg BE
Public Health; 2022 Aug; 209():e3-e4. PubMed ID: 35718555
[No Abstract] [Full Text] [Related]
2. Tailored vs. General COVID-19 prevention for adults with mental disabilities residing in group homes: a randomized controlled effectiveness-implementation trial.
Bartels S; Levison JH; Trieu HD; Wilson A; Krane D; Cheng D; Xie H; Donelan K; Bird B; Shellenberger K; Cella E; Oreskovic NM; Irwin K; Aschbrenner K; Fathi A; Gamse S; Holland S; Wolfe J; Chau C; Adejinmi A; Langlois J; Reichman JL; Iezzoni LI; Skotko BG
BMC Public Health; 2024 Jun; 24(1):1705. PubMed ID: 38926810
[TBL] [Abstract][Full Text] [Related]
3. Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trial.
Levison JH; Krane D; Donelan K; Aschbrenner K; Trieu HD; Chau C; Wilson A; Oreskovic NM; Irwin K; Iezzoni LI; Xie H; Samuels R; Silverman P; Batson J; Fathi A; Gamse S; Holland S; Wolfe J; Shellenberger K; Cella E; Bird B; Skotko BG; Bartels S
Contemp Clin Trials; 2023 Feb; 125():107053. PubMed ID: 36539061
[TBL] [Abstract][Full Text] [Related]
4. The Role of Information and Knowledge in COVID-19 Vaccination Among People With Intellectual and Developmental Disabilities and Their Families.
Lineberry S; Bogenschutz M; Dinora P; Ayers K
Intellect Dev Disabil; 2023 Feb; 61(1):16-30. PubMed ID: 36706004
[TBL] [Abstract][Full Text] [Related]
5. Supported COVID-19 Vaccination Pathways for Adolescents and Young Adults With Significant Challenging Behaviours and Developmental Disability.
Garg P; Reid N; Lai T; Kent A; Crewes S; Roberts K
J Paediatr Child Health; 2022 Sep; 58(9):1707-1709. PubMed ID: 35869695
[No Abstract] [Full Text] [Related]
6. Important Considerations for COVID-19 Vaccination of Children With Developmental Disabilities.
Tinker SC; Cogswell ME; Peacock G; Ryerson AB
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34272340
[No Abstract] [Full Text] [Related]
7. Nutritional intervention improves menu adequacy in group homes for adults with intellectual or developmental disabilities.
Humphries K; Pepper A; Traci MA; Olson J; Seekins T
Disabil Health J; 2009 Jul; 2(3):136-44. PubMed ID: 21122752
[TBL] [Abstract][Full Text] [Related]
8. Drive through COVID19 vaccination for developmentally disabled persons.
Reidenberg BE; Hirsch K; Costello CM; Russo M; Reilly M; Murphy P
Vaccine; 2022 Apr; 40(16):2365-2366. PubMed ID: 34663505
[No Abstract] [Full Text] [Related]
9. Risk Factors Associated With COVID-19 Outcomes Among People With Intellectual and Developmental Disabilities Receiving Residential Services.
Landes SD; Turk MA; Damiani MR; Proctor P; Baier S
JAMA Netw Open; 2021 Jun; 4(6):e2112862. PubMed ID: 34100935
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 precautions experienced by a sample of adults with intellectual and developmental disabilities.
Hansford R; Ouellette-Kuntz H; Péfoyo AK; Martin L
Ann Epidemiol; 2022 Nov; 75():10-15. PubMed ID: 36031096
[TBL] [Abstract][Full Text] [Related]
11. Pre- and Post-COVID-19 Outcomes for Israelis With Intellectual and Developmental Disabilities in the Community.
Gur A; Soffer M; Blanck PD; Quinn G; Rimmerman A
Intellect Dev Disabil; 2023 Dec; 61(6):454-467. PubMed ID: 38011742
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the usefulness of a wordless picture book for adults with intellectual disabilities about the COVID-19 vaccination programme using co-production: The CAREVIS study.
Wythe H; Attavar R; Jones J; Kelly J; Palmer C; Jenkins L; Dekker R; Fearns D; Watkins S; Hunt A; Pattison N
J Appl Res Intellect Disabil; 2024 Mar; 37(2):e13203. PubMed ID: 38369311
[TBL] [Abstract][Full Text] [Related]
13. Management and support of individuals with developmental disabilities during the COVID-19 pandemic.
Dimitriou D; Esposito G
Res Dev Disabil; 2022 Jun; 125():104228. PubMed ID: 35358826
[No Abstract] [Full Text] [Related]
14. Changes in community and hospital-based health care use during the COVID-19 pandemic for adults with and without intellectual and developmental disabilities.
Durbin A; Balogh R; Lin E; Palma L; Plumptre L; Lunsky Y
J Intellect Disabil Res; 2022 May; 66(5):399-412. PubMed ID: 35353400
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccine perceptions in New York State's intellectual and developmental disabilities community.
Iadarola S; Siegel JF; Gao Q; McGrath K; Bonuck KA
Disabil Health J; 2022 Jan; 15(1):101178. PubMed ID: 34362712
[TBL] [Abstract][Full Text] [Related]
16. Short Report: The influence of congregate setting on positive COVID-19 tests among a high-risk sample of adults with intellectual and developmental disability in Ontario.
Hansford R; Ouellette-Kuntz H; Martin L
Res Dev Disabil; 2022 Mar; 122():104178. PubMed ID: 35063714
[TBL] [Abstract][Full Text] [Related]
17. Social support as a mediator of stress and life satisfaction for people with intellectual or developmental disabilities during the COVID-19 pandemic.
Fisher MH; Sung C; Kammes RR; Okyere C; Park J
J Appl Res Intellect Disabil; 2022 Jan; 35(1):243-251. PubMed ID: 34633129
[TBL] [Abstract][Full Text] [Related]
18. Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.
Muhsen K; Maimon N; Mizrahi A; Varticovschi B; Bodenheimer O; Gelbshtein U; Grotto I; Cohen D; Dagan R
N Engl J Med; 2022 Jan; 386(4):399-401. PubMed ID: 34936758
[No Abstract] [Full Text] [Related]
19. COVID-19 and Persons With Intellectual and Developmental Disabilities: Implications for Future Policy, Practice, and Research.
Hewitt AS; Smith JG; Weintraub L
Am J Intellect Dev Disabil; 2022 Jul; 127(4):270-277. PubMed ID: 36122325
[TBL] [Abstract][Full Text] [Related]
20. Examining the development and utilization of infection control policies to safely support adults with intellectual and developmental disabilities in congregate living settings during COVID-19.
Freeman M; Crawford A; Gough L; Rianto M; Yakubov R; Rampton G; FitzGerald E; Fang H; Di Rezze B
Can J Public Health; 2022 Dec; 113(6):918-929. PubMed ID: 36068435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
